india

India: Creating An Innovative Healthcare Ecosystem

At the Organization of Pharmaceuticals Producers of India (OPPI), the association representing the research-based pharmaceutical companies in India, putting the patient at the center of all that they do is…

Africa: The Launchpad for Indian Pharma

Although most industry observers expect that Indian pharma exports to the US will pick up again in the coming…

Gender Diversity in Indian Pharma

India could boost its GDP by USD 0.7 trillion in 2025 by matching the rate of improvement of gender equality of the…

India: An Emerging Knowledge Superpower

“India, as a manufacturing hub, offers safe, effective, quality medicines, at the very best prices. Now, we…

In Conversation

RS Raghav, founder and managing director of Oaknet Healthcare, documents the key fundamentals that have enabled Oaknet to proudly become a Top 100 player in the competitive Indian market within only three years of existence. Looking forward, he also documents the importance of in-licensing partnerships, digitalization, and the company’s expertise in identifying unmet market needs to further propel its growth…

India Pharma Market Facts & Figures Snapshot

India’s pharmaceutical sales and forecast from 2013 up to 2021. Between 2017 and 2021, the Indian pharma…

How Beneficial Is The Recent Price Control Exemption For Innovative Drugs In…

Anay Shukla leads the pharmaceutical, life sciences, med-tech and healthcare practice at Nishith Desai Associates,…

India: Still a Land of Opportunity for MNCs

For multinational companies, despite ‘pharmerging markets’ not holding the hype and allure they once did, India…

Quality Compliance in Indian Pharma: The Learning Curve

One issue grinding the gears of the Indian pharmaceutical industry over recent years has been quality compliance.…

10 Pharma Leaders to Know in India

Indian pharma companies provide affordable generic drugs to patients in almost all countries across the globe,…

MNCs’ Healthcare Access Initiatives in India

With the Indian public healthcare apparatus straining at the seams to provide affordable access to treatments to…

Indian Biosimilars: Going Global

Deloitte predicts that the global market for biosimilars will reach between USD 25 and 35 billion by 2020, driven…

Colombia: The Great Indian Investment Wave

With the onset of universal public healthcare, new types of foreign actors have been spying fresh opportunities to…

Indian Pharma Manufacturing: Serving the World

Indian pharma production is growing rapidly – boosted by the Modi government’s ‘Make in India’ campaign…

Indian Contract Research Industry Set for Rapid Growth

The global pharmaceutical outsourcing market was estimated to be USD 115.7 billion in 2016, of which 49 percent is…

India’s Drug Regulatory Reforms: Building Trust

Dilip Shah, the Secretary-General of the Indian Pharmaceutical Alliance advocates for a stronger and more…